Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PEOPLE - Roche makes appointment:

This article was originally published in Clinica

Executive Summary

Anton Affentranger, currently CEO of Lombard Odier Group in Geneva, Switzerland, has been appointed chief financial officer of Roche. Mr Affentranger will replaces Henri Meier, who is retiring at the end of the year. Two further appointments to the executive committee include William Burns, who becomes head of Roche's pharmaceutical division in January and replaces Franz Humer, who will concentrate on his role as CEO of the Roche Group. Richard Laube will join the executive committee, with worldwide responsibility for Roche's OTC business.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076997

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel